To further verify that the NOTCH3 enhancer promotes the tumor-initiating activity of NRF2-activated NSCLC cells, we conducted a serial transplantation assay and compared the frequency of tumorigenesis (Fig. 9e and Supplementary Fig. 13d, e). The gene discussed is NFE2L2; the disease is neoplasm.